TScan Therapeutics, Inc. (TCRX)
25 filings available.
3
Insider buys, 12 months
$146K by 1 insider
0
Insider sales, 12 months
$0 by 0 insiders
Most active TCRX insiders: Lynx1 Capital Management LP.
Loading activity recap...
Loading insider activity...
Loading institutional activity...
Loading fund comparison...
Loading contract awards...
Loading activity heatmap...
Full Timeline
Every tracked SEC filing, congressional trade, 13F/N-PORT holding change, lobbying disclosure, government contract award, SEC enforcement action, and pay-vs-performance filing for TCRX, merged into one feed.
Loading timeline...
Who's involved
Loading the people and funds behind TCRX…
Get instant alerts the moment TCRX files, trades, or shows up in Congress, 13F, or lobbying data — right on your phone.
Get the app →Recent filings
- TScan Therapeutics Reports Board Resignations and Committee Changes8-KOct 16, 2026
- TScan Therapeutics CEO Granted 1.0M RSUs Tied to Pivotal Trial4Oct 2, 2026Filed by MacBeath Gavingrant · 1,000,000 shares